November 13,2019 Dear Director and The Manager of SET Re: Operating Performance’s Summary of Q3/2019 During the third quarter of 2019, total sales amount of the Company was 27 6.71 million baht. It
similar to the case of public offering. Additionally, rehabilitation information must also be disclosed, such as the Rehabilitation Plan and a summary of such plan, and significant related risks, etc. The
increase the normal capacity during off peak power usage in 4th Quarter of 2017. - Gain from debt restructuring was achieved of THB 734 million some portion resulting from debt-to-equity conversion scheme in
20240205-ADVANC-MDA-4Q23-EN 4Q23 & FY23 MD&A Advanced Info Service Plc. 1 Executive Summary Achieved solid revenue growth from core business focus and TTTBB acquisitions. FY23, the Thai economy
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2018 as follows. Summary The Company
Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the yearly period at the end of 31st December 2019 as follows. Summary The Company
of Solvay Biochemicals (Taixing) Limited (“SBT”) amounting to 218 MB. Summary of Performance For Q2 2017, the Company and its subsidiaries recorded net profit of 384 MTHB, increased by 249 MTHB or 5.0
. * Note Please find further information in the consolidated financial statements. 2 Summary of Performance For Q3 2017, the Company and its subsidiaries recorded net profit of 355 MTHB, increased by 267
Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 31st March 2019 as follows. Summary
%) by compared with the net profit at 121.68 million baht same period at last year. The changing over than 20% from the main causes as follows: Summary of important financial information amount percent